Early-stage AI Target opportunity as a startup in medical device AI with an initial hospital-focused artificial pancreas project, presenting a chance to position health tech solutions and AI-enabled glucose management products to hospital systems and ICU units.

Hospital Use Case Emphasize procurement and integration pathways for hospital settings, highlighting the AI-based glucose controller’s potential to improve patient outcomes and reduce costs, appealing to hospital risk managers and clinical engineering teams.

Regulatory/Navigator Across FDA validation support and regulatory navigation services, offer partnership or advisory solutions to accelerate approvals, leveraging prior collaboration with JKI to position as a value-added facilitator for early-stage medtech developers.

Financing Signals Leverage past debt financing as proof of interest and feasibility; pursue conversations with niche medical device investors, lenders, and grant programs focused on AI in critical care to support scaling and regulatory milestones.

Cloud and Security Fit Position to offer secure cloud-based data management, telemetry, and compliance-ready infrastructure (Google Cloud, Cloudflare, reCAPTCHA) to prospective hospital customers and partners seeking robust, scalable, and secure medical device ecosystems.